Gathering quality data during remote sessions begins with ensuring participants are equally as comfortable as they would be during an in-person session.
Back to team page
Kaitlin Stinson
Director
Kaitlin brings to Bold Insight over 14 years of experience as a human factors engineer at medical device manufacturers. She has extensive experience in diabetes care products, software as medical device (SaMD), and complex drug delivery systems. Kaitlin has a passion for meeting design control and regulatory requirements while executing agile human factors programs of research. She has a BS in Psychology from Ball State University and an MS in Human Factors from Bentley University.



Bold facts
Learn more about

Something unique about you summed up in one sentence:

Your favorite part of working at Bold Insight:

In your spare time (or if you had spare time), you would absolutely do this:

Your favorite city in the world is...and why?

You cannot start the day without doing this:

Your ultimate celebrity dinner party guest list would include:

Long-term personal or professional goal?

Favorite quote:
- Bold Insight presents with Stryker, Genentech, and AbbVie at the HFES Healthcare Symposium
- Integrating FDA's new cybersecurity guidance into medical device human factors engineering processes
- Bold Insight and Eli Lilly and Company co-publish journal article on novel assessment tool to enhance medical device usability
- Bold Insight to launch AI research project at the 2024 HFES Health Care Symposium
Read our team’s latest bold insights
3 tips to successfully onboard in a remote environment
A focus on building connections and involvement with remote co-workers is key in both successful onboarding for new employees as well as employee retention.
Reflecting on an unprecedented year with mixed emotions
With optimism, we reflect on a year of new challenges as we await the return of our ‘old’ normal.
5 tips to mitigate use-related risk for pre-filled syringes and other injection devices
Attention to logistics, thoughtful product and research study design, and iterative user testing can help mitigate use-related risk with injection devices.